GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (LTS:0QBO) » Definitions » Cyclically Adjusted Price-to-FCF

Coloplast AS (LTS:0QBO) Cyclically Adjusted Price-to-FCF : 37.15 (As of Jun. 05, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Coloplast AS Cyclically Adjusted Price-to-FCF?

As of today (2025-06-05), Coloplast AS's current share price is kr630.40. Coloplast AS's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was kr16.97. Coloplast AS's Cyclically Adjusted Price-to-FCF for today is 37.15.

The historical rank and industry rank for Coloplast AS's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

LTS:0QBO' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 37.16   Med: 55.5   Max: 86.54
Current: 37.5

During the past years, Coloplast AS's highest Cyclically Adjusted Price-to-FCF was 86.54. The lowest was 37.16. And the median was 55.50.

LTS:0QBO's Cyclically Adjusted Price-to-FCF is ranked worse than
50.81% of 248 companies
in the Medical Devices & Instruments industry
Industry Median: 36.435 vs LTS:0QBO: 37.50

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Coloplast AS's adjusted free cash flow per share data for the three months ended in Mar. 2025 was kr1.917. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is kr16.97 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coloplast AS Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Coloplast AS's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Cyclically Adjusted Price-to-FCF Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.94 68.89 46.43 44.66 54.26

Coloplast AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.75 52.55 54.26 47.36 42.67

Competitive Comparison of Coloplast AS's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, Coloplast AS's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Cyclically Adjusted Price-to-FCF falls into.


;
;

Coloplast AS Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Coloplast AS's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=630.40/16.97
=37.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Coloplast AS's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1.917/120.2000*120.2000
=1.917

Current CPI (Mar. 2025) = 120.2000.

Coloplast AS Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 4.556 100.300 5.460
201509 5.713 100.200 6.853
201512 2.369 99.800 2.853
201603 1.703 100.200 2.043
201606 2.112 100.600 2.523
201609 5.020 100.200 6.022
201612 0.669 100.300 0.802
201703 0.725 101.200 0.861
201706 4.470 101.200 5.309
201709 6.196 101.800 7.316
201712 3.813 101.300 4.524
201803 1.320 101.700 1.560
201806 5.540 102.300 6.509
201809 6.715 102.400 7.882
201812 3.014 102.100 3.548
201903 1.498 102.900 1.750
201906 5.697 102.900 6.655
201909 7.254 102.900 8.474
201912 3.784 102.900 4.420
202003 1.689 103.300 1.965
202006 5.696 103.200 6.634
202009 6.788 103.500 7.883
202012 -0.085 103.400 -0.099
202103 2.430 104.300 2.800
202106 5.420 105.000 6.205
202109 7.824 105.800 8.889
202112 4.361 106.600 4.917
202203 -0.089 109.900 -0.097
202206 6.182 113.600 6.541
202209 8.189 116.400 8.456
202212 0.998 115.900 1.035
202303 1.874 117.300 1.920
202306 4.128 116.400 4.263
202309 6.662 117.400 6.821
202312 6.735 116.700 6.937
202403 -12.612 118.400 -12.804
202406 5.062 118.500 5.135
202409 7.113 118.900 7.191
202412 7.541 118.900 7.623
202503 1.917 120.200 1.917

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coloplast AS  (LTS:0QBO) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Coloplast AS Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines